
Lauren Papenhausen
Partner at White & Case LLP specializing in white-collar defense and healthcare litigation, with expertise in regulatory compliance and government investigations
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Jul 6, 2026
From Price Strategy to Enforcement Risk
5:10
5:26
5:36
5:53

Lauren PapenhausenGUEST
So everything that we're going to talk about today really lives in the shadow of these two statutes that you mentioned, the False Claims Act and the Anti-Kickback Statute.

Lauren PapenhausenGUEST
At a very basic level, it says that you cannot knowingly submit a false claim for payment to the federal government.

Lauren PapenhausenGUEST
In the drug world, what this means is that every time a prescription is filled for a Medicare or Medicaid patient, a claim goes to the government, and the amount that the government pays is driven by pricing data the manufacturer reported.

Lauren PapenhausenGUEST
Things like average sales price for Part B drugs and average manufacturer price and best price for Medicaid So you have a simple chain.
16 MINS LATER